May 27, 2022
Daiichi Sankyo said on May 26 that its investigational mRNA vaccine against COVID-19 (DS-5670) demonstrated efficacy in a domestic booster dose trial. The results of this first dose-finding part in the Japan PI/II/III clinical study showed that the booster effect...read more